Cytel
Cytel, officially known as Cytel Inc., is a leading provider of advanced statistical software and services, headquartered in the United States. Founded in 1981, the company has established a strong presence in the biostatistics and clinical trial sectors, with major operational regions across North America, Europe, and Asia. Cytel is renowned for its innovative solutions in clinical development, particularly its software products like East and StatXact, which streamline the design and analysis of clinical trials. These offerings are distinguished by their robust statistical methodologies and user-friendly interfaces, catering to the needs of pharmaceutical and biotechnology companies. With a commitment to enhancing the efficiency of clinical research, Cytel has achieved significant milestones, including partnerships with leading global organisations. Its reputation as a trusted partner in the industry underscores its market position and dedication to advancing healthcare through data-driven insights.
DitchCarbon Score
How does Cytel's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cytel's score of 33 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cytel's reported carbon emissions
In 2023, Cytel Inc. reported total greenhouse gas emissions of approximately 7,126,650 kg CO2e, with emissions distributed across various scopes: 3,570 kg CO2e from Scope 1, 47,270 kg CO2e from Scope 2 (market-based), and a significant 7,121,010 kg CO2e from Scope 3. The Scope 3 emissions included major contributions from purchased goods and services (4,863,000 kg CO2e), business travel (896,300 kg CO2e), and employee commuting (1,072,700 kg CO2e). Cytel has set ambitious reduction targets through the Science Based Targets initiative (SBTi). The company commits to reducing its absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2022 as the baseline. Additionally, Cytel aims to decrease its Scope 3 emissions by 51.6% per million USD value added within the same timeframe. These targets align with the necessary reductions to limit global warming to 1.5°C, demonstrating Cytel's commitment to addressing climate change effectively. The emissions data and reduction targets are sourced directly from Cytel Inc., with no data cascaded from a parent or related organization.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 63,400 | 00,000 | 0,000 |
| Scope 2 | 95,600 | 000,000 | 00,000 |
| Scope 3 | 1,814,220 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cytel is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
